Federal award
ROCHE DIAGNOSTICS CORPORATION
W81K0222P0104
Contract
Obligated and Ceiling
- Obligated (net)
- $3,009,762.49
- Ceiling (potential value, not spending)
- $4,665,198.25
- Current value
- $4,665,198.25
- Gross positive obligations
- $5,371,886.17
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- ROCHE DIAGNOSTICS CORPORATION · JDMDFEZBYH36
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- ROCHE HOLDING AG · WJHDT127L353
- Awarding agency
- Department of War · sub-agency 97DH · office HT9410
- Funding agency
- Department of War · sub-agency 97DH
- Product or service (PSC)
- 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
- Industry (NAICS)
- 325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
- PIID
- W81K0222P0104
- Award type code
- B
- Actions
- 22 · Sep 15, 2022 to Jul 2, 2026
- Why it is listed
- gross positive obligations of $100k or more (contracts)
Action History22
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Jul 2, 2026 | FY2026 | P00021 | B | $100,000.00 | — |
| Apr 9, 2026 | FY2026 | P00020 | M | $0.00 | — |
| Apr 3, 2026 | FY2026 | P00019 | M | $0.00 | — |
| Jan 27, 2026 | FY2026 | P00018 | C | $1,415,435.76 | — |
| Jan 26, 2026 | FY2026 | P00017 | B | −$150,037.62 | — |
| Jul 18, 2025 | FY2025 | P00016 | G | $0.00 | — |
| Jun 25, 2025 | FY2025 | P00015 | B | $194,928.36 | — |
| Oct 29, 2024 | FY2025 | P00014 | B | $1,220,507.40 | — |
| Sep 13, 2024 | FY2024 | P00013 | G | $0.00 | — |
| Jul 30, 2024 | FY2024 | P00012 | B | −$135,000.00 | — |
| Jul 3, 2024 | FY2024 | P00011 | B | −$165,000.00 | — |
| May 24, 2024 | FY2024 | P00010 | B | −$165,000.00 | — |
| Apr 4, 2024 | FY2024 | P00009 | B | −$276,578.81 | — |
| Jan 9, 2024 | FY2024 | P00008 | B | −$485,507.25 | — |
| Oct 11, 2023 | FY2024 | P00007 | C | $1,220,507.40 | — |
| Sep 13, 2023 | FY2023 | P00006 | B | −$235,000.00 | — |
| Jul 31, 2023 | FY2023 | P00005 | B | $0.00 | — |
| Jun 16, 2023 | FY2023 | P00004 | B | −$250,000.00 | — |
| May 18, 2023 | FY2023 | P00003 | M | $0.00 | — |
| Jan 11, 2023 | FY2023 | P00002 | B | −$500,000.00 | — |
| Oct 24, 2022 | FY2023 | P00001 | C | $1,220,507.25 | — |
| Sep 15, 2022 | FY2022 | 0 | — | $0.00 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.